Clinical trial

Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics

NCT03002389

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2017-11-05

PhasePHASE2

Study timeline

Study start (actual)2017-11-05Date precision: day

Registry last updated2024-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

Anoro ElliptaDRUG

Arnuity ElliptaDRUG

Sponsors & collaborators

University of Virginialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03002389 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.